The many faces of globular glial tauopathy: A clinical and imaging study
暂无分享,去创建一个
Joseph James Duffy | R. Petersen | J. Graff‐Radford | B. Boeve | V. Lowe | D. Dickson | D. Knopman | K. Josephs | H. Botha | F. Ali | N. Pham | S. Koga | A. Nguyen | M. Buciuc | R. Reichard | J. Whitwell | Marina Buciuc | Farwa Ali | Jon Graff-Radford
[1] C. Counsell,et al. Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome , 2022, Movement disorders clinical practice.
[2] Rene L. Utianski,et al. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy , 2021, Movement disorders : official journal of the Movement Disorder Society.
[3] J. Keller,et al. Corpus callosum hypersignals and focal atrophy: Neuroimaging findings in globular glial tauopathy type I , 2021, European journal of neurology.
[4] J. Kril,et al. Association Between Globular Glial Tauopathies and Frontotemporal Dementia-Expanding the Spectrum of Gliocentric Disorders: A Review. , 2021, JAMA neurology.
[5] A. Murzin,et al. Structure-based classification of tauopathies , 2021, Nature.
[6] N. Matsukawa,et al. Rapid Progression of White Matter Signal Changes and Frontotemporal Atrophy in Globular Glial Tauopathy. , 2020, Journal of neuropathology and experimental neurology.
[7] Rene L. Utianski,et al. Sensitivity–Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration , 2020, Annals of neurology.
[8] M. Hasegawa,et al. Globular glial tauopathy Type I presenting with behavioral variant frontotemporal dementia , 2020, Neuropathology : official journal of the Japanese Society of Neuropathology.
[9] J. Keller,et al. Globular Glial Tauopathy Type I Presenting as Atypical Progressive Aphasia, With Comorbid Limbic-Predominant Age-Related TDP-43 Encephalopathy , 2019, Front. Aging Neurosci..
[10] David T. Jones,et al. Tau-positron emission tomography correlates with neuropathology findings , 2019, Alzheimer's & Dementia.
[11] David T. Jones,et al. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes , 2019, Brain : a journal of neurology.
[12] C. Jack,et al. White matter hyperintensities: relationship to amyloid and tau burden. , 2019, Brain : a journal of neurology.
[13] J. Lanciego,et al. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings , 2019, Journal of Neurology.
[14] J. Hodges,et al. Heritability in frontotemporal tauopathies , 2019, Alzheimer's & dementia.
[15] D. Dickson,et al. Globular Glial Tauopathy May be Mistaken for Corticobasal Syndrome—Pointers for the Clinician , 2018, Movement disorders clinical practice.
[16] K. Josephs. Rest in peace FTDP-17. , 2018, Brain : a journal of neurology.
[17] J. Hodges,et al. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies , 2017, Brain : a journal of neurology.
[18] Keith A. Johnson,et al. Flortaucipir tau PET imaging in semantic variant primary progressive aphasia , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[19] Myung Jun Lee,et al. Globular glial tauopathy presenting as non-fluent/agrammatic variant primary progressive aphasia with chorea. , 2017, Parkinsonism & related disorders.
[20] Murray Grossman,et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.
[21] H. Imai,et al. [An Autopsy Case of Globular Glial Tauopathy Presenting with Amyotrophic Lateral Sclerosis with Dementia]. , 2016, Brain and nerve = Shinkei kenkyu no shinpo.
[22] J. Hodges,et al. Expanding the phenotypic associations of globular glial tau subtypes , 2016, Alzheimer's & dementia.
[23] L. Petrucelli,et al. A novel tau mutation, p.K317N, causes globular glial tauopathy , 2015, Acta Neuropathologica.
[24] J. McCarten,et al. A Case of Globular Glial Tauopathy Presenting Clinically as Alzheimer Disease , 2015, Alzheimer disease and associated disorders.
[25] Janna H. Neltner,et al. Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.
[26] V. Lowe,et al. FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants , 2014, Journal of Neurology.
[27] Isidro Ferrer,et al. Globular glial tauopathies (GGT): consensus recommendations , 2013, Acta Neuropathologica.
[28] Mark Hallett,et al. Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.
[29] C. Jack,et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech , 2012, Brain : a journal of neurology.
[30] C. Jack,et al. Imaging correlates of pathology in corticobasal syndrome , 2010, Neurology.
[31] William T. Hu,et al. Anatomical differences between CBS‐corticobasal degeneration and CBS‐Alzheimer's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[32] J. Whitwell. Voxel-Based Morphometry: An Automated Technique for Assessing Structural Changes in the Brain , 2009, The Journal of Neuroscience.
[33] C. Jack,et al. Very early semantic dementia with progressive temporal lobe atrophy: an 8-year longitudinal study. , 2008, Archives of neurology.
[34] B. Ghetti,et al. White Matter Tauopathy With Globular Glial Inclusions: A Distinct Sporadic Frontotemporal Lobar Degeneration , 2008, Journal of neuropathology and experimental neurology.
[35] F. Tagliavini,et al. Atypical tauopathy with massive involvement of the white matter , 2008, Neuropathology and applied neurobiology.
[36] Wen-Lang Lin,et al. Atypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration , 2006, Journal of neuropathology and experimental neurology.
[37] B. Ghetti,et al. A novel leukoencephalopathy associated with tau deposits primarily in white matter glia , 2003, Acta Neuropathologica.
[38] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[39] D. Dickson. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration , 1999, Journal of Neurology.
[40] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[42] J. Graff‐Radford,et al. Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia. , 2016, JAMA neurology.